1896
Articles published
Join thousands of students achieving their dreams with expert-led courses.
Join free and unlock everything on EasyShiksha.
Takes less than 3 seconds โ no password needed
Please enter a valid email address.
Checking your emailโฆ
Almost done โ just verify your number so we can send course updates and certificates.
Used only for verification & updates
Incorrect OTP. Please try again.
Takes less than 10 seconds
Please select your country.
Please select your state.
The manufacturing, testing, release and distribution of vaccines is a complex and multifactorial process with hundreds of steps, requiring a diverse pool of human resources. For vaccines to result in actual vaccination of people, highly coordinated efforts are required from international supply chain, manufacturers, regulators and State and Central government agencies.
Production scale-up of vaccines is a step-by-step process, involving several regulatory SOPs of GMP (Standard Operating Procedures of Good Manufacturing Practices). There is a four-month lag time for COVAXINยฎ to translate into actual vaccination.
The timeline for manufacturing, testing and release for a batch of COVAXINยฎ is approximately 120 days, depending on the technology framework and regulatory guidelines to be met. Thus, production batches of COVAXINยฎ that were initiated during March this year will be ready for supply only during the month of June.
Based on Central Drugs Standard Control Organisation(CDSCO) guidelines, all vaccines supplied in India are mandated by law to be submitted for testing and release to the Central Drugs Laboratory, Government of India. All batches of vaccines supplied to State and Central Governments are based on the allocation framework received from the Government of India.
The timeline for vaccine supplies to reach the depots of the State and Central Governments from Bharat Biotechโs facilities is around two days. The vaccines received at these depots have to be further distributed by the State Governments to various districts within their respective states. This requires additional number of days. Pandemic vaccines are distributed by respective governments equitably across all sections of the population. Vaccines once available at the vaccination centers are then administered to recipients over a period of time, based on demand.
About Bharat Biotech
Bharat Biotech has established an excellent track record of innovation with more than 145 global patents, a wide product portfolio of more than 16 vaccines, 4 bio-therapeutics, registrations in more than 123 countries, and the World Health Organization (WHO) Pre-qualifications. Located in Genome Valley in Hyderabad, India, a hub for the global biotech industry, Bharat Biotech has built a world-class vaccine & bio-therapeutics, research & product development, Bio-Safety Level 3 manufacturing, and vaccine supply and distribution.
Having delivered close to 5 billion doses of vaccines worldwide, Bharat Biotech continues to lead innovation and has developed vaccines for influenza H1N1, Rotavirus, Japanese Encephalitis (JENVACยฎ), Rabies, Chikungunya, Zika, Cholera, and the worldโs first tetanus-toxoid conjugated vaccine for Typhoid. Bharatโs commitment to global social innovation programs and public-private partnerships resulted in introducing path-breaking WHO pre-qualified vaccines BIOPOLIOยฎ, ROTAVACยฎ, and Typbar TCVยฎ combatting polio, rotavirus, typhoid infections, respectively. The acquisition of Chiron Behring Vaccines, has positioned Bharat Biotech as the world's largest rabies vaccine manufacturer with Chirorabยฎ and Indirabยฎ.
To learn more about Bharat Biotech, visit www.bharatbiotech.com.
More News Click here
Discover thousands of colleges and courses, enhance skills with online courses and internships, explore career alternatives, and stay updated with the latest educational news..
Gain high-quality, filtered student leads, prominent homepage ads, top search ranking, and a separate website. Let us actively enhance your brand awareness.
Download EasyShiksha Mobile Apps from Android Play Store, Apple App Store, Amazon App Store, and Jio STB.
1 million+ย learned on the EasyShiksha App
Trusted by Standards & Global Compliance Frameworks
Built under internationally recognized standards for quality, information security, educational excellence and business continuity.
ISO 9001:2015 | ISO/IEC 27001:2022 | ISO 21001:2018 | ISO 22301:2019 | DPIIT Recognized Startup | MSME Registered
